Rockwell Medical IN (RMTI)
0.9600 x 7 1.0900 x 20
Post-market by (Cboe BZX)
1.0600 -0.0100 (-0.93%) 04/11/25 [NASDAQ]
0.9600 x 7 1.0900 x 20
Post-market 1.0300 -0.0300 (-2.83%) 16:35 ET
for Fri, Apr 11th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -480 | -8,439 | -18,679 | -32,674 | -30,890 |
Depreciation Amortization | 4,566 | 4,561 | 2,958 | 2,884 | 2,583 |
Accounts receivable | 2,610 | -4,642 | -346 | -1,742 | 32 |
Accounts payable and accrued liabilities | -1,647 | 463 | 314 | -416 | 1,136 |
Other Working Capital | -1,527 | -7,244 | -2,126 | -4,843 | -2,958 |
Other Operating Activity | 680 | 5,889 | 950 | 3,257 | 456 |
Operating Cash Flow | $4,202 | $-9,412 | $-16,929 | $-33,534 | $-29,641 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -3,855 | 9,600 | -2,115 | 833 | 4,258 |
PPE Investments | -1,011 | -284 | -281 | -522 | -1,046 |
Net Acquisitions | N/A | -12,361 | N/A | N/A | N/A |
Investing Cash Flow | $-4,866 | $-3,045 | $-2,396 | $311 | $3,212 |
Cash Flows From Financing Activities | |||||
Debt Issued | N/A | N/A | -1,443 | N/A | 22,500 |
Debt Repayment | -1,204 | -3,514 | -12,232 | -750 | N/A |
Common Stock Issued | 10,181 | 14,861 | 15,016 | 107 | 45,473 |
Common Stock Repurchased | N/A | N/A | N/A | -6 | -19 |
Other Financing Activity | -1,629 | -5 | 14,809 | -1,530 | -4,638 |
Financing Cash Flow | $7,348 | $11,342 | $16,150 | $-2,179 | $63,316 |
Exchange Rate Effect | -5 | -4 | -3 | N/A | N/A |
Beginning Cash Position | 8,983 | 10,102 | 13,280 | 48,682 | 11,795 |
End Cash Position | 15,662 | 8,983 | 10,102 | 13,280 | 48,682 |
Net Cash Flow | $6,679 | $-1,119 | $-3,178 | $-35,402 | $36,887 |
Free Cash Flow | |||||
Operating Cash Flow | 4,202 | -9,412 | -16,929 | -33,534 | -29,641 |
Capital Expenditure | -1,011 | -284 | -281 | -522 | -1,046 |
Free Cash Flow | 3,191 | -9,696 | -17,210 | -34,056 | -30,687 |